ACR Appropriateness Criteria® Definitive Therapy for Early-Stage Cervical Cancer

Small, William; Strauss, Jonathan B.; Jhingran, Anuja; Yashar, Catheryn M.; Cárdenes, Higinia R.; Erickson-Wittmann, Beth A.; Gullett, Norleena; Kidd, Elizabeth A.; Lee, Larissa J.; Mayr, Nina A.; Moore, David H.; Puthawala, Ajmel; Rao, Gautam; Varia, Mahesh A.; Wahl, Andrew O.; Wolfson, Aaron H.; Yuh, William T. C.; Gaffney, David K.

doi:10.1097/coc.0b013e3182610537

Cited by 19 publications

(19 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(Pecorelli et al, 2009) However, its utility is low in guiding adjuvant therapy (Hricak et al, 2005). Although clinicopathologic factors have been suggested to guide postoperative adjuvant therapy selection, controversy surrounding the independence of these factors for prognosis of cervical cancer patients still exists (Chang et al, 2009;Small et al, 2012). These different results may be due to the heterogeneity of the population enrolled in different studies (Kamura et al, 1992;Yuan et al, 1998;Ho et al, 2004;Singh et al, 2012).…”

Section: Discussionmentioning

confidence: 57%

“…Although NCCN (Grochola et al, 2008)guidelines have suggested that adjuvant therapy should be applied to certain patients with intermediate or high risk factors after surgery, these factors remain controversial in many studies (Kamura et al, 1992;Yuan et al, 1998;Creasman and Kohler, 2004;Ho et al, 2004;Chang et al, 2009;Singh et al, 2012;Williams et al, 2015). Therefore, different opinions on the impact of prognostic factors between studies may lead to various selection criteria for adjuvant therapy, as suggested by researchers (Chang et al, 2009;Small et al, 2012).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection

Zhou¹,

Xiong²,

Zhang³

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 57%

Section: Introductionmentioning

confidence: 99%

Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection

Zhou¹,

Xiong²,

Zhang³

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…However, the investigators of a prospective trial showed that 18 F‐FDG PET/CT had a minimal effect on preoperative decisions regarding local disease . Elsewhere, CT was shown to have only modest sensitivity and specificity in diagnosing parametrial invasion …”

Section: Introductionmentioning

confidence: 99%

“…18 Elsewhere, CT was shown to have only modest sensitivity and specificity in diagnosing parametrial invasion. 19 This study is a retrospective description of the management of the patients with cervical cancer in one single institution based on the physical examination, high-detail TVS, and 18 F-FDG PET/CT, in the decision triage of patients with cervical cancer to surgery or chemoradiation therapy. For the purpose of this study, the final histology of the surgical specimens was compared with the results of the TVS and 18 F-FDG PET/CT to assess the contribution of these imaging modalities to the treatment decision.…”

Section: Introductionmentioning

confidence: 99%

The added benefit of transvaginal sonography in the clinical staging of cervical carcinoma

Goldberg

Siegler

Segev

et al. 2019

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

Introduction Patients diagnosed with cervical cancer face several treatment options, depending on the physical examination and the imaging modality results. Transvaginal sonography (TVS) was proposed as an imaging option to determine local spread of cervical tumors, along with magnetic resonance imaging, also by recently released International Federation of Gynecology and Obstetrics recommendations. We examined whether combined data from physical examination, high‐detail TVS, and positron emission tomography with 18F‐labeled fluoro‐2‐deoxyglucose and computed tomography (18F‐FDG PET/CT) may contribute to triage efficiency of cervical cancer patients. Material and methods This is a retrospective study of consecutive women diagnosed with cervical cancer at the Carmel Health Center, Haifa, Israel, during 2010‐2015. Inclusion criteria were histology of cervical cancer and the availability of three modalities—a thorough physical examination, a high‐detail TVS, and positron emission tomography (PET) with 18F‐FDG and computed tomography (18F‐FDG PET/CT). End points were the possibility to predict local invasion to the parametrium and distant lymph node metastasis at the time of triage to surgery or chemoradiation. Results Seventy‐three patients with cervical cancer were evaluated. TVS correctly predicted no involvement of the parametrium for the 25 who had a postoperative pathological report. TVS measurement of tumor dimension was also matched by the pathological report in these cases. Only three patients were referred for adjuvant therapy according to postoperative pathology criteria. Among 43 women treated with a combination of chemotherapy and radiotherapy due to advanced disease, and with complete data, at least two modalities were congruent with chemoradiation for 33 (77%). Three patients (7%) were referred to chemoradiation due to TVS result alone. Conclusions The combination of high‐detail TVS, directed to predict tumor dimensions and local spread, performed by a trained operator, combined with 18F‐FDG PET/CT and physical examination, can assist in selecting optimal treatment for cervical cancer patients, thus avoiding unnecessary operations.

show abstract

“…This information is of great value for practitioners in choosing appropriate imaging modalities for the assessment of cervical cancers and endometrial cancers (27)(28)(29).…”

Section: Pet/ct Imagingmentioning

confidence: 99%

Imaging across the Life Span: Innovations in Imaging and Therapy for Gynecologic Cancer

Xu‐Welliver¹,

Yuh²,

Macura

et al. 2014

RadioGraphics

Self Cite

View full text Add to dashboard Cite

The focus of this article is radiation therapy for gynecologic cancers, with emphasis on imaging-based treatment planning and delivery. For the various gynecologic cancers, radiation oncologists rely on essential clinical information to triage treatment options, and various imaging studies are performed for treatment planning and radiation therapy delivery. A practical approach is provided to help radiologists tailor their reports for the needs of their radiation oncology and gynecologic oncology colleagues, to optimize multidisciplinary care for patients with gynecologic cancer. Template radiology reports are proposed to address the specific information needs of oncologists at each phase-before, during, and after treatment. Fueled by the rapid progress in engineering and computer sciences during the past 2 decades, remarkable advances have been made in anatomic, functional, and molecular imaging and in radiation treatment planning and delivery in patients with gynecologic cancer. Radiation therapy has evolved from a nontargeted approach to a precisely targeted, highly conformal treatment modality, to further improve treatment outcomes and reduce morbidity. Highquality imaging has become essential for staging of the disease, delineation of tumor extent for treatment planning and delivery, and monitoring therapy response. Anatomic and functional imaging has also been shown to provide prognostic information that allows clinicians to tailor therapy on the basis of personalized patient information. This field is an area of active research, and future clinical trials are warranted to validate preliminary results in the field.

show abstract

ACR Appropriateness Criteria® Definitive Therapy for Early-Stage Cervical Cancer

Abstract: This manuscript represents the consensus opinion of an expert panel based on a survey of all available medical literature. This manuscript may be used to inform the clinical decision making of physicians involved in the treatment of early-stage cervical cancer.

Cited by 19 publications

References 53 publications

Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection

Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection

The added benefit of transvaginal sonography in the clinical staging of cervical carcinoma

Imaging across the Life Span: Innovations in Imaging and Therapy for Gynecologic Cancer

Contact Info

Product

Resources

About